These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22127372)

  • 1. Kinetic energy density and agglomerate abrasion rate during blending of agglomerates into powders.
    Willemsz TA; Hooijmaijers R; Rubingh CM; Tran TN; Frijlink HW; Vromans H; van der Voort Maarschalk K
    Eur J Pharm Sci; 2012 Jan; 45(1-2):211-5. PubMed ID: 22127372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Stokes number approach to support scale-up and technology transfer of a mixing process.
    Willemsz TA; Hooijmaijers R; Rubingh CM; Frijlink HW; Vromans H; van der Voort Maarschalk K
    AAPS PharmSciTech; 2012 Sep; 13(3):928-33. PubMed ID: 22733375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blending of agglomerates into powders 1: Quantification of abrasion rate.
    Willemsz TA; Oostra W; Hooijmaijers R; de Vegt O; Morad N; Vromans H; Frijlink HW; Van der Voort Maarschalk K
    Int J Pharm; 2010 Mar; 387(1-2):87-92. PubMed ID: 20015470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative characterization of agglomerate abrasion in a tumbling blender by using the Stokes number approach.
    Willemsz TA; Nguyen TT; Hooijmaijers R; Frijlink HW; Vromans H; van der Voort Maarschalk K
    AAPS PharmSciTech; 2013 Mar; 14(1):183-8. PubMed ID: 23250711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug.
    Alyami H; Dahmash E; Bowen J; Mohammed AR
    PLoS One; 2017; 12(6):e0178772. PubMed ID: 28609454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved blend and tablet properties of fine pharmaceutical powders via dry particle coating.
    Huang Z; Scicolone JV; Han X; Davé RN
    Int J Pharm; 2015 Jan; 478(2):447-55. PubMed ID: 25475016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commercial scale validation of a process scale-up model for lubricant blending of pharmaceutical powders.
    Kushner J; Schlack H
    Int J Pharm; 2014 Nov; 475(1-2):147-55. PubMed ID: 25152166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving powder flow properties of a cohesive lactose monohydrate powder by intensive mechanical dry coating.
    Zhou Q; Armstrong B; Larson I; Stewart PJ; Morton DA
    J Pharm Sci; 2010 Feb; 99(2):969-81. PubMed ID: 19795479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations.
    Le VN; Robins E; Flament MP
    Eur J Pharm Biopharm; 2012 Apr; 80(3):596-603. PubMed ID: 22198291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of material attributes and process parameters on the powder bed uniformity during a low-dose dosator capsule filling process.
    Stranzinger S; Faulhammer E; Calzolari V; Biserni S; Dreu R; Šibanc R; Paudel A; Khinast JG
    Int J Pharm; 2017 Jan; 516(1-2):9-20. PubMed ID: 27826028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Powder flow in an automated uniaxial tester and an annular shear cell: a study of pharmaceutical excipients and analytical data comparison.
    Kuentz M; Schirg P
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1476-83. PubMed ID: 23043592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.
    Shalash AO; Molokhia AM; Elsayed MM
    Eur J Pharm Biopharm; 2015 Oct; 96():291-303. PubMed ID: 26275831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of powder flow properties on capsule filling weight uniformity.
    Osorio JG; Muzzio FJ
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1464-75. PubMed ID: 23902366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the effects of high shear blending on lactose and drug using fluidised bed elutriation.
    Willetts JP; Robbins PT; Roche TC; Bowley M; Bridson RH
    Int J Pharm; 2012 Sep; 434(1-2):272-9. PubMed ID: 22683647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-line quantification of drug and excipients in cohesive powder blends by near infrared spectroscopy.
    Liew CV; Karande AD; Heng PW
    Int J Pharm; 2010 Feb; 386(1-2):138-48. PubMed ID: 19922776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of interactions between powder particle size and binder viscosity on agglomerate growth mechanisms in a high shear mixer.
    Johansen A; Schaefer T
    Eur J Pharm Sci; 2001 Jan; 12(3):297-309. PubMed ID: 11113649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact milling of pharmaceutical agglomerates in the wet and dry states.
    Schenck LR; Plank RV
    Int J Pharm; 2008 Feb; 348(1-2):18-26. PubMed ID: 17804181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roller compaction of moist pharmaceutical powders.
    Wu CY; Hung WL; Miguélez-Morán AM; Gururajan B; Seville JP
    Int J Pharm; 2010 May; 391(1-2):90-7. PubMed ID: 20176096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic time scales in adhesive mixing investigated by dry particle sizing.
    Nguyen D; Rasmuson A; Niklasson Björn I; Thalberg K
    Eur J Pharm Sci; 2015 Mar; 69():19-25. PubMed ID: 25576090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of the surface energy of lubricated pharmaceutical powders by inverse gas chromatography.
    Swaminathan V; Cobb J; Saracovan I
    Int J Pharm; 2006 Apr; 312(1-2):158-65. PubMed ID: 16469458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.